» Articles » PMID: 16116613

Brain Atrophy Rates in Parkinson's Disease with and Without Dementia Using Serial Magnetic Resonance Imaging

Overview
Journal Mov Disord
Date 2005 Aug 24
PMID 16116613
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Increased rates of brain atrophy are seen in Alzheimer's disease, but whether rates are similarly increased in other dementias such as Parkinson's disease dementia (PDD) has not been well examined. We determined the rates of brain atrophy using serial magnetic resonance imaging (MRI) in PDD and compared this finding to rates seen in cognitively intact Parkinson's disease (PD) patients and age-matched control subjects. Thirty-one patients (PD = 18, PDD = 13) and 24 age-matched controls underwent serial volumetric 1.5 T MRI scans, approximately 1 year apart. Baseline and repeat scans were registered and quantification of the brain boundary shift integral was used to determine whole-brain atrophy rates. Rates of brain atrophy were significantly increased in PDD (1.12 +/- 0.98%/year) compared to PD (0.31 +/- 0.69%/year; P = 0.018) and control subjects (0.34 +/- 0.76%/year; P = 0.015). There were no differences in atrophy rates between controls and PD (P = 0.79). No correlations between increased atrophy rates and age or dementia severity (Mini-Mental State Examination score) were observed. Serial MRI may be a useful tool for monitoring disease progression in PDD and further studies should investigate its utility for early diagnosis.

Citing Articles

Morphological basis of Parkinson disease-associated cognitive impairment: an update.

Jellinger K J Neural Transm (Vienna). 2022; 129(8):977-999.

PMID: 35726096 DOI: 10.1007/s00702-022-02522-4.


Current advances in metabolomic studies on non-motor psychiatric manifestations of Parkinson's disease (Review).

Ciobanu A, Ionita I, Buleandra M, David I, Popa D, Ciucu A Exp Ther Med. 2021; 22(3):1010.

PMID: 34345292 PMC: 8311266. DOI: 10.3892/etm.2021.10443.


Prefrontal and hippocampal atrophy using 7-tesla magnetic resonance imaging in patients with Parkinson's disease.

Oh B, Moon H, Kim A, Kim H, Cheong C, Park Y Acta Radiol Open. 2021; 10(2):2058460120988097.

PMID: 33786201 PMC: 7958639. DOI: 10.1177/2058460120988097.


Neuroimaging in aging and neurologic diseases.

Risacher S, Saykin A Handb Clin Neurol. 2019; 167:191-227.

PMID: 31753134 PMC: 9006168. DOI: 10.1016/B978-0-12-804766-8.00012-1.


Longitudinal white matter microstructural change in Parkinson's disease.

Pozorski V, Oh J, Adluru N, Merluzzi A, Theisen F, Okonkwo O Hum Brain Mapp. 2018; 39(10):4150-4161.

PMID: 29952102 PMC: 6128734. DOI: 10.1002/hbm.24239.